StockTipsArenaBeta

BUY Torrent Pharmaceuticals Limited — Shrikant Chouhan, Kotak Securities

BUYTorrent Pharmaceuticals Limited
Torrent Pharmaceuticals share price target & all analyst calls

byShrikant Chouhan, Kotak SecuritiesHorizon: 1–3 months29 Sept 2026via CNBC Awaaz.

Entry₹4,935Inferred
Target₹5,100
Total upside +3.34%
Stop lossNot given
CMP₹4,6701d ago
Active-5.37%+9.21%upside left 6 wk left
Follow Shrikant Chouhan for new calls(46% target hit, 37 closed calls)Get alertsWatch TORNTPHARM for new buy/sell callsGet alertsSee 84 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:27 am IST
4 supporting1 neutral5 opposing
Supports the BUY call (4)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

10 advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · adjacent horizon·5 Nov · 1w ago

Neutral / worth noting (1)

Torrent Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·23 Oct · 3w ago

(opens in new tab)
Weighs against the BUY call (5)

Torrent Pharma Q2 Results: Net profit declines despite 51% revenue growth; misses estimates

NewsCnbc-Tv18·23 Oct · 3w ago

(opens in new tab)

Torrent accepts Kelshikar resignation: October 23 call for Torrent Pharmaceuticals stock

NewsGoogle News·19 Oct · 4w ago

(opens in new tab)

Torrent Pharmaceuticals accepts resignation of Executive Director Amal Kelshikar

NewsGoogle News·16 Oct · 4w ago

(opens in new tab)

Torrent Pharmaceuticals (NSE:TORNTPHARM): Who Has Resigned as Executive Director?

NewsGoogle News·16 Oct · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Torrent Pharmaceuticals

All analyst calls on Torrent Pharmaceuticals

More from Shrikant Chouhan, Kotak Securities

Every call and its outcome